FDA Form 483 Warning Letter - What next?

tallu

Involved In Discussions
#1
I your FDA 483 response is not adequate, you will receive Warning Letter.

If your Warning Letter response is not adequate, what happens? Does the FDA comes visit your facilities and shut down manufacturing or do they just ban your device(s) from US markets?
 
Elsmar Forum Sponsor
J

Jim-S

#3
Based on my own experience, the question isn't only what steps the FDA will take against the company. An important factor in how these issues resolve is in how your company addresses them internally. Does the company take the observations seriously and make a firm effort to address them or does it simply try to defend it's existing practice?

The company I work at initially responded to a 483 by sticking by their existing practices. Rather than correcting the issues they simply blamed the inspector. Naturally this was a bad idea. Eventually our internal thinking changed and true efforts to address the observations were taken. Unfortunately, the culture hasn't changed. An evironment still exists in which all other departments feel empowered to challenge each and ever Quality Assurance decision.
 

Ronen E

Problem Solver
Staff member
Moderator
#4
I your FDA 483 response is not adequate, you will receive Warning Letter.

If your Warning Letter response is not adequate, what happens? Does the FDA comes visit your facilities and shut down manufacturing or do they just ban your device(s) from US markets?
Hi,

FDA doesn't have jurisdiction to "shut down manufacturing" outside the USA. They may ask to visit your premises (I don't think that is a likely step following an inadequate response to a warning letter), and they may very well ban your products from entry into the USA, as well as a host of other sanctions (that could involve other USA authorities as well - they explicitly say that in warning letters). they may also share their findings and actions with regulatory authorities in countries other than the USA, which may then take their own steps... Best to avoid this situation.

Cheers,
Ronen.
 

Mark Meer

Trusted Information Resource
#5
Anyone know if the FDA has any specified timelines with respect to their review of responses to warning letters & resolutions?

A quick look at the FDA Warning Letters page shows there are a ton of unresolved warnings dating back for years...

Furthermore, many that are resolved show dates spanning years between issuance and resolution.

Not sure if this reflects:
a) a backlog of paperwork (wouldn't surprise me)
b) lack of updates to the webpage (wouldn't surprise me either)
c) that most of these company's responses to date are inadequate and hence the files are still unresolved
 
M

MIREGMGR

#6
During the period between Warning Letter issuance and close-out, the subject company is in a heightened-oversight situation. Multiple short-notice or no-notice FDA inspections may occur. FDA may do a lot of "fishing" through records, and camp out at the company. This can go on for a long time if FDA thinks the subject company is sufficiently important to justify the focus.

A major global OEM's medical imaging equipment operation got a warning letter several years ago for poor control practices in software development among other problems. They were on shipment hold for something like two years and were inspected, IIRC, five times before FDA finally granted them a close-out.

It made quite a difference to that division's operations and profit contribution. Their line of US made equipment essentially was terminated due to reputation damage and operational disruption.
 

Mark Meer

Trusted Information Resource
#7
So, in otherwords, there is no time-frame...? Companies can potentially just leave their status unresolved and stay in the "heightened-oversight situation" indefinitely?

Given the sheer number of unresolved warnings spanning years, I guess this might be the case for some of them...

I can't help but think that in most cases, however, it might be largely a backlog on the FDA side... I can only imagine that for some companies, their responses are hundreds or even thousands of pages... and given the FDA's reputation for scrutiny, that's a lot of paper to (finely) comb over. Not to mention all the new cases pouring in...
 
M

MIREGMGR

#8
Certainly in the case of the imaging equipment company I referenced, it did take the FDA a long time to evaluate their catch-up design control work. As I understand, they were required to retroactively design-control and document all of the design-related activity for which FDA was not satisfied as to records, that had occurred over a number of years.

In some cases, a warning letter is associated with an FDA-required field action. In those instances, FDA also won't issue a closeout until the field action reaches an FDA-determined success threshold. For a field action extending back years, it can be very difficult and expensive to find units in the field and convince customers to cooperate, and/or to document in an FDA-satisfactory manner that units have been used, discarded or otherwise are no longer available. In instances where units have been used, FDA sometimes has required that documentation be provided that proper medical review was provided to each individual patient involved at no cost to them, to assure that their involvement with the recalled device had no unreported adverse effects.

Inability to get to the FDA-required recall threshold was one of the factors in the referenced medical imaging company situation, I think.
 
Thread starter Similar threads Forum Replies Date
J Manufacturing CRL - Class 1 or Class 2 Inspection (FDA form 483) US Food and Drug Administration (FDA) 1
E How to Respond to a US FDA untitled letter - Form 483 or Warning Letter Other US Medical Device Regulations 2
C Response by FDA for Form 483 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
E FDA - Audit - Response - Observation form 483. Do we now receive a formal letter? US Food and Drug Administration (FDA) 5
gunnyshore Form FDA 3500A MedWatch eSubmitter 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
M Informational US FDA – Ethicon Recalls Circular Staplers for Insufficient Firing and Failure to Completely Form Staples Medical Device and FDA Regulations and Standards News 0
S Where did FDA 510(K) form 3654 go? Other US Medical Device Regulations 1
JoshuaFroud FDA Form MDSAP AU F0029.1.004 - Help with Completion US Food and Drug Administration (FDA) 0
Ronen E FDA issues draft guidance on form & content of UDI Other US Medical Device Regulations 0
S Any experience on filling form, FDA 3654 for the DICOM standard? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
T Inspection Form Review And Approval - FDA Requirements ISO 13485:2016 - Medical Device Quality Management Systems 2
I Small Business Qualification Certification Submission - FDA Form 3602 US Food and Drug Administration (FDA) 5
Y ISO 13485:2003 &FDA QSR (21 CFR 820) Quality Manual,34 Procedures and Form Book, Video, Blog and Web Site Reviews and Recommendations 8
Q Financial Disclosure of Clinical Investigators - FDA Form 3455 (Financial Disclosure) Other US Medical Device Regulations 1
S FDA Form 3613 [Certificate to Foreign Government (CFG)] - Manufacturer Information 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 14
D How to use FDA Form 3654 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 4
B Filling Out FDA Form 3654 when Testing is Incomplete 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D Lean SCAR Process and Form needed - ISO 13485 and FDA ISO 13485:2016 - Medical Device Quality Management Systems 8
S FDA Annual Registration - Any harm to be FDA (form FDA 2891a) registrated 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
A FDA Class Classification for a cabinet 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
L FDA Biocompatibility Requirements - Transitory Contact Other US Medical Device Regulations 1
Edward Reesor FDA DM and /or Class I Life Saving US Food and Drug Administration (FDA) 0
Watchcat FDA will not tolerate fraud…meaning what, exactly? Other US Medical Device Regulations 6
K FDA Premarket Cybersecurity Guidance - 4 questions Other US Medical Device Regulations 2
Watchcat FDA Webinar Series - N95 Respirators Other US Medical Device Regulations 0
M Off-Label Use - Clarification of FDA Policy US Food and Drug Administration (FDA) 1
J Sub-supplier change from manual to automated process - same specs - Report to FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
C FDA Establishment registration - Buying some medical devices from another manufacturer Medical Device and FDA Regulations and Standards News 5
I How to classify a medical device based on FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
dinaroxentool Question about FDA Classification of a Device 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
S The US FDA requirements on Disposal of a medical device US Food and Drug Administration (FDA) 1
S FDA Requirements for Medical Device Label Reconciliation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S What is considered a "core algorithm"? (From an FDA guidance document) Medical Information Technology, Medical Software and Health Informatics 4
B FDA-Medical Device Reporting (MDR )procedure compliant with 21CFR section 803 US Food and Drug Administration (FDA) 0
Stoic Are any medical device companies using the 2011 FDA process validation guidance instead of GHTF/SG3/N99-10:2004? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D ISO 13485, FDA 21 CFR 820 and Auditing the Accounting Department ISO 13485:2016 - Medical Device Quality Management Systems 5
S FDA's E submitter - For clinical electronic thermometer Medical Device and FDA Regulations and Standards News 6
J FDA wants electrical safety testing on battery powered medical device US Food and Drug Administration (FDA) 8
A FDA and NB audit of Engineering Drawings in DHF and DMR. Medical Device and FDA Regulations and Standards News 1
D FDA De Novo Cover Letter - What is expected US Food and Drug Administration (FDA) 3
Ed Panek 21 CFR Part 820 - FDA Label Requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
J Mislabeling - Consider this an FDA notified recall? CFR 806.10 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
O Hospital-Developed, In-House Device - FDA Clearance? Other US Medical Device Regulations 19
D FDA Approved Class II Medical Device? Other US Medical Device Regulations 11
R When does the FDA consider a component a medical device? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 17
N Risk Management besides mandated FDA requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
M Informational US FDA – Ear, Nose, and Throat Devices; Classification of the Self-Fitting Air-Conduction Hearing Aid Medical Device and FDA Regulations and Standards News 0
L UDI Requirments Gap Analysis - EU MDR vs FDA CFR EU Medical Device Regulations 8
M Informational US FDA – Modifications to the List of Recognized Standards, Recognition List Number: 052 Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication Medical Device and FDA Regulations and Standards News 0
Similar threads


















































Top Bottom